A randomised, placebo-controlled, multicentre, Phase 2 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia-Reference-Cited by-同舟云学术

A randomised, placebo-controlled, multicentre, Phase 2 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia

Published:2018-05-04 Issue:2 Volume:122 Page:283-292
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Moon Kyong Tae¹,Yoo Tag Keun¹,Kwon Se Yun²,Ha Ji Yong³,Byun Seok Soo⁴,Kim Jang Hwan⁵,Chung Jae Il⁶,Kim Tae Hyoung⁷,Moon Hong Sang⁸,Kim Sang Jae⁹,Lee Kyung Seop²

Affiliation:

1. Department of Urology; Eulji General Hospital; Eulji University School of Medicine; Seoul Korea

2. Department of Urology; Dongguk University Gyeongju Hospital; Dongguk University College of Medicine; Gyeongju Korea

3. Department of Urology; Keimyung University School of Medicine; Daegu Korea

4. Department of Urology; Seoul National University Bundang Hospital; Seoul National University College of Medicine; Seongnam Korea

5. Departments of Urology; Yonsei University College of Medicine; Seoul Korea

6. Department of Urology; Busan Paik Hospital; Inje University; Busan Korea

7. Department of Urology; College of Medicine; ChungAng University; Seoul Korea

8. Department of Urology; Hanyang University College of Medicine; Seoul Korea

9. Teloid Inc.; Los Angeles CA USA

Publisher

Wiley